Tengion Inc

(TNGN)

By |

Profile

Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.

Contact Information

Website: www.tengion.com
Email: ir@tengion.com
Main Phone: +1 336 722-5855
Address: 3929 Westpoint Boulevard
Address 2: Suite G
State: NC
City / Town: Winston-Salem
Country: USA
Postal Code: 27103

Issuer Information

Exchange: OTO
CEO: John L. Miclot
Employees: 27
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,245,124.00 EPS (TTM) -0.92 PE Ratio N/A Exchange OTCPK